WO2017030383A3 - 바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물 - Google Patents
바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물 Download PDFInfo
- Publication number
- WO2017030383A3 WO2017030383A3 PCT/KR2016/009085 KR2016009085W WO2017030383A3 WO 2017030383 A3 WO2017030383 A3 WO 2017030383A3 KR 2016009085 W KR2016009085 W KR 2016009085W WO 2017030383 A3 WO2017030383 A3 WO 2017030383A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- bakuchiol
- preventing
- active ingredient
- muscular dystrophy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
보골지에서 유래된 바쿠치올을 유효성분으로 함유하는 근육위축증 예방 및 치료용 약학적 조성물을 제공한다. 상기 약학적 조성물은 근육세포 재생촉진 및 근육세포로의 분화유도에 효과적이다.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2015-0117371 | 2015-08-20 | ||
| KR1020150117371A KR101725327B1 (ko) | 2015-08-20 | 2015-08-20 | 바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2017030383A2 WO2017030383A2 (ko) | 2017-02-23 |
| WO2017030383A3 true WO2017030383A3 (ko) | 2017-05-11 |
Family
ID=58050824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2016/009085 WO2017030383A2 (ko) | 2015-08-20 | 2016-08-18 | 바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101725327B1 (ko) |
| WO (1) | WO2017030383A2 (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101997336B1 (ko) | 2017-07-18 | 2019-07-08 | 연세대학교 산학협력단 | 에틸바닐린을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 |
| KR101923153B1 (ko) * | 2018-08-02 | 2018-11-28 | 충남대학교산학협력단 | 갈산을 유효성분으로 포함하는 근 분화 촉진용 조성물 |
| KR20220055890A (ko) * | 2020-10-27 | 2022-05-04 | 애니머스큐어 주식회사 | Cdo 단백질 또는 이를 암호화하는 유전자를 포함하는 신경 근육 질환의 예방 또는 치료용 조성물 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000007648A (ko) * | 1998-07-06 | 2000-02-07 | 서경배 | !보골지 추출물 및/또는 바쿠치올을 유효성분으로 하는 시클로옥시게나제-2 저해제 및 보골지추출물 및/또는 바쿠치올을 함유하는 항염증 화장료 |
| US20040043089A1 (en) * | 2002-09-04 | 2004-03-04 | Rabie A-Bakr M | Buguzhi agent and composition and methods of preparing and administering the same |
| JP2005330200A (ja) * | 2004-05-19 | 2005-12-02 | Yasuo Ito | 下肢の運動機能改善薬、下肢の筋肉増強薬、器質萎縮性疼痛の軽減薬および抗転移性骨腫瘍剤 |
| KR20080016609A (ko) * | 2005-05-09 | 2008-02-21 | 유니젠 파아마슈티컬스,인크. | 바쿠치올의 조성물 및 그것의 제조방법 |
| KR100833652B1 (ko) * | 2006-12-28 | 2008-05-29 | 한국화학연구원 | Ｂａｃｅ-1의 활성을 저해하는 파고지 종자 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4069817B2 (ja) | 2003-07-10 | 2008-04-02 | 住友電装株式会社 | コネクタ |
-
2015
- 2015-08-20 KR KR1020150117371A patent/KR101725327B1/ko active IP Right Grant
-
2016
- 2016-08-18 WO PCT/KR2016/009085 patent/WO2017030383A2/ko active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000007648A (ko) * | 1998-07-06 | 2000-02-07 | 서경배 | !보골지 추출물 및/또는 바쿠치올을 유효성분으로 하는 시클로옥시게나제-2 저해제 및 보골지추출물 및/또는 바쿠치올을 함유하는 항염증 화장료 |
| US20040043089A1 (en) * | 2002-09-04 | 2004-03-04 | Rabie A-Bakr M | Buguzhi agent and composition and methods of preparing and administering the same |
| JP2005330200A (ja) * | 2004-05-19 | 2005-12-02 | Yasuo Ito | 下肢の運動機能改善薬、下肢の筋肉増強薬、器質萎縮性疼痛の軽減薬および抗転移性骨腫瘍剤 |
| KR20080016609A (ko) * | 2005-05-09 | 2008-02-21 | 유니젠 파아마슈티컬스,인크. | 바쿠치올의 조성물 및 그것의 제조방법 |
| KR100833652B1 (ko) * | 2006-12-28 | 2008-05-29 | 한국화학연구원 | Ｂａｃｅ-1의 활성을 저해하는 파고지 종자 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170022427A (ko) | 2017-03-02 |
| KR101725327B1 (ko) | 2017-04-10 |
| WO2017030383A2 (ko) | 2017-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
| WO2016064082A3 (ko) | 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도 | |
| NZ761388A (en) | Methods of treatment for cystic fibrosis | |
| WO2016109663A3 (en) | Derivatives and methods of treating hepatitis b infections | |
| MY195002A (en) | Benzoxazepin oxazolidinone compounds and methods of use | |
| WO2016149401A3 (en) | Piperazine carbamates and methods of making and using same | |
| WO2016044556A3 (en) | Arginine methyltransferase inhibitors and uses thereof | |
| WO2016106331A8 (en) | Mutant idh1 inhibitors useful for treating cancer | |
| WO2015160975A3 (en) | Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer | |
| EP4327887A3 (en) | Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular disease | |
| EP4218823A3 (en) | Novel polymeric hgh prodrugs | |
| CA2908742C (en) | Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer | |
| WO2016025666A8 (en) | Tissue matrices and methods of treatment | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| WO2015106215A3 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| WO2017030383A3 (ko) | 바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물 | |
| EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
| EP3539978A4 (en) | NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT | |
| EP3311817A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF EYES DISEASES WITH IMATINIB AS AN ACTIVE SUBSTANCE | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| EP3167893A4 (en) | Pharmaceutical composition containing spirulina maxima extract as active ingredient for preventing and treating retinal diseases | |
| EP4364810A3 (en) | Topical formulations and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16837325 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16837325 Country of ref document: EP Kind code of ref document: A2 |